205
Views
4
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Cost-utility of azithromycin in patients with severe asthma

, MD, PhDORCID Icon, , RN, MSc & , MD, MSc
Pages 2008-2015 | Received 24 Jun 2021, Accepted 09 Sep 2021, Published online: 22 Sep 2021

References

  • To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet L-P. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204. doi:10.1186/1471-2458-12-204.
  • Asher MI, Garcia-Marcos L, Pearce NE, Strachan DP. Trends in worldwide asthma prevalence. Eur Respir J. 2020;56(6):56.
  • Dean BB, Calimlim BC, Sacco P, Aguilar D, Maykut R, Tinkelman D. Uncontrolled asthma: assessing quality of life and productivity of children and their caregivers using a cross-sectional Internet-based survey . Health Qual Life Outcomes. 2010;8:96. doi:10.1186/1477-7525-8-96.
  • Hekking PW, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. There is a high prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015; 135 (4):8996.
  • Yaghoubi M, Adibi A, Safari A, FitzGerald JM, Sadatsafavi M. The projected economic and health burden of uncontrolled asthma in the United States. Am J Respir Crit Care Med. 2019; 200(9):1102–1112. doi:10.1164/rccm.201901-0016OC.
  • Ekici A, Ekici M, Kemal Erdemoğlu A. The effect of azithromycin on the severity of bronchial hyper responsiveness in patients with mild asthma is unknown. J Asthma. 2002; 39(2):181–185. doi:10.1081/JAS-120002199.
  • Wang Q, Yu M-F, Zhang W-J, Liu B-B, Zhao Q-Y, Luo X, Xu H, She Y-S, Zang D-A, Qiu J-Y, et al. Azithromycin inhibits muscarinic 2 receptor-activated and voltage-activated Ca2+ permeant ion channels and Ca2+ sensitization, relaxing airway smooth muscle contraction. Clin Exp Pharmacol Physiol. 2019;46(4):329–336. doi:10.1111/1440-1681.13062.
  • Hiles SA, McDonald VM, Guilhermino M, Brusselle GG, Gibson PG. Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis. Eur Respir J. 2019;54(5):1901381. doi:10.1183/13993003.01381-2019.
  • Asthma GIf. Global Strategy for Asthma Management and Prevention; 2021. [accessed May 6, 2021]. https://ginasthma.org/.
  • Florez-Tanus A, Parra D, Zakzuk J, Caraballo L, Alvis-Guzman N. Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis. World Allerg Organization J. 2018; 11(1) :26. doi:10.1186/s40413-018-0205-4.
  • Shrestha P, Cooper BS, Coast J, Oppong R, Do Thi Thuy N, Phodha T, Celhay O, Guerin PJ, Wertheim H, Lubell Y, et al. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use. Antimicrob Resist Infect Control. 2018;7:98. doi:10.1186/s13756-018-0384-3.
  • Einarson TR, Bereza BG, Nielsen TA, Hemels ME. Utilities for asthma and COPD according to category of severity: a comprehensive literature review. J Med Econ. 2015;18 (7):550–563. doi:10.3111/13696998.2015.1025793.
  • Lloyd A, Price D, Brown R. The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK. Prim Care Respir J. 2007;16(1):22–27. doi:10.3132/pcrj.2007.00002.
  • Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, et al. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390(10095):659–668. doi:10.1016/S0140-6736(17)31281-3.
  • Hong SH, Cho JY, Kim TB, Lee EK, Kwon SH, Shin JY. Cost-Effectiveness of Tiotropium in elderly patients with severe asthma using real-world data. J Allergy Clin Immunol Pract. 2021;9(5):1939-1947.e7. doi:10.1016/j.jaip.2020.11.052.
  • Brusselle GG, Vanderstichele C, Jordens P, Deman R, Slabbynck H, Ringoet V, Verleden G, Demedts IK, Verhamme K, Delporte A, et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax. 2013;68(4):322–329. doi:10.1136/thoraxjnl-2012-202698.
  • O’Neill C, Gibson PG, Heaney LG, Upham JW, Yang IA, Reynolds PN, Hodge S, Jenkins CR, Peters M, Marks GB, et al. The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma. Eur Respir J. 2021;57(2):2002436. doi:10.1183/13993003.02436-2020.
  • Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E, CHEERS Task Force, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Value Health. 2013;16(2):e1–e5. doi:10.1016/j.jval.2013.02.010.
  • (DANE) DNdE. Archivo nacional de datos; 2019. https://sitios.dane.gov.co/anda-index/.
  • Jacob C, Haas JS, Bechtel B, Kardos P, Braun S. Assessing asthma severity based on claims data: a systematic review. Eur J Health Econ. 2017;18(2):227–241. doi:10.1007/s10198-016-0769-2.
  • Neffen H, Fritscher C, Schacht FC, Levy G, Chiarella P, Soriano JB, Mechali D, AIRLA Survey Group. Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey. Rev Panam Salud Publica. 2005;17(3):191–197. doi:10.1590/s1020-49892005000300007.
  • Morales-Munera O, Pedraza A, Nino-Serna L. [Omalizumab in children with uncontrolled asthma: a real-life study carried out in Colombia]. Mexican J Allergy. 2018;65(3):222–232.
  • Salud IdETe. Manual metodológico para la elaboración de evaluaciones de efectividad, seguridad y validez diagnóstica de tecnologías en salud. Bogota DC; 2014. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/IETS/manual-metodologico-elaboracion-de-evaluaciones-de-efectividad.pdf.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.